naltrexone bupropion Contrave
Selected indexed studies
- Medications for Obesity: A Review. (JAMA, 2024) [PMID:39037780]
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (Lancet, 2010) [PMID:20673995]
- Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR. (Drugs R D, 2010) [PMID:20509712]
_Worker-drafted node — pending editorial review._
Connections
naltrexone bupropion Contrave is a side effect of
Sources
- Naltrexone/bupropion for obesity. (2017) pubmed
- Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR. (2010) pubmed
- Bupropion and Naltrexone in Methamphetamine Use Disorder. (2021) pubmed
- Medications for Obesity: A Review. (2024) pubmed
- Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial. (2023) pubmed
- Naltrexone-Bupropion. (2012) pubmed
- Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial. (2022) pubmed
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (2010) pubmed
- Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review. (2022) pubmed
- Management of obesity. (2016) pubmed